未登录

P

Pablo Laborda

Rigshospitalet

H指数:20

被引数:1,100

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Host-pathogen-immune interactions in an air-liquid interface airway model

宿主-病原体-免疫相互作用在气-液界面气道模型中

Frontiers in Cellular and Infection Microbiology

IF4.8

2026-04-100

OAAI

Carbapenem-resistance oprD mutations reshape Pseudomonas aeruginosa host-pathogen interactions during infection

碳青霉烯耐药性oprD突变重塑铜绿假单胞菌在感染期间的宿主-病原体相互作用

Nature Communications

IF15.7

2026-04-100

OAAI

Rethinking antimicrobial resistance diagnostics: beyond standardized susceptibility testing

重新审视抗菌药物耐药性诊断：超越标准化药敏试验

Trends in Microbiology

IF14.9

2026-04-030

PRE

Use of adjuvants to improve antibiotic efficacy and reduce the burden of antimicrobial resistance

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY

IF3.8

2024-12-270

PRE

Macrolide resistance through uL4 and uL22 ribosomal mutations in Pseudomonas aeruginosa

NATURE COMMUNICATIONS

IF15.7

2024-10-160

OAAI

Preserving the efficacy of antibiotics to tackle antibiotic resistance

MICROBIAL BIOTECHNOLOGY

IF5.2

2024-07-170

OA

Role of bacterial multidrug efflux pumps during infection

WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY

IF4.2

2024-06-014

PRE

Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance

NATURE COMMUNICATIONS

IF15.7

2024-03-226

OAAI

Translating eco-evolutionary biology into therapy to tackle antibiotic resistance

NATURE REVIEWS MICROBIOLOGY

IF103.3

2023-05-1926

PRE

Efflux in Gram-negative bacteria: what are the latest opportunities for drug discovery?

EXPERT OPINION ON DRUG DISCOVERY

IF4.9

2023-05-1811

PRE

Tackling antibiotic resistance by inducing transient and robust collateral sensitivity

NATURE COMMUNICATIONS

IF15.7

2023-03-3017

OAAI

Crosstalk between Pseudomonas aeruginosa antibiotic resistance and virulence mediated by phenylethylamine

MICROBIAL BIOTECHNOLOGY

IF5.2

2023-03-284

OAAI

Rapid Phenotypic Convergence towards Collateral Sensitivity in Clinical Isolates of Pseudomonas aeruginosa Presenting Different Genomic Backgrounds

MICROBIOLOGY SPECTRUM

IF3.8

2023-02-1410

OAAI

Evolution of Habitat-Dependent Antibiotic Resistance in Pseudomonas aeruginosa

铜绿假单胞菌生境依赖性抗生素耐药性的演变

MICROBIOLOGY SPECTRUM

IF3.8

2022-08-3113

OAAI

Mutational background influences P. aeruginosa ciprofloxacin resistance evolution but preserves collateral sensitivity robustness

突变背景影响铜绿假单胞菌环丙沙星耐药性演变，但保持侧支敏感性稳健性

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2022-04-0621

OAAI

Rapid decline of ceftazidime resistance in antibiotic-free and sub-lethal environments is contingent on genetic background

MOLECULAR BIOLOGY AND EVOLUTION

IF5.3

2022-03-1516

OAAI

Pseudomonas aeruginosa: an antibiotic resilient pathogen with environmental origin

CURRENT OPINION IN MICROBIOLOGY

IF7.5

2021-12-0147

OAAI

Mode of action and efficacy of quinolinic acid for the control of Ceratocystis fimbriata on sweet potato

PEST MANAGEMENT SCIENCE

IF3.8

2021-06-2214

PREAI

Convergent phenotypic evolution towards fosfomycin collateral sensitivity of Pseudomonas aeruginosa antibiotic-resistant mutants

MICROBIAL BIOTECHNOLOGY

IF5.2

2021-05-0722

OAAI

Discovery of inhibitors of Pseudomonas aeruginosa virulence through the search for natural-like compounds with a dual role as inducers and substrates of efflux pumps

ENVIRONMENTAL MICROBIOLOGY

IF4

2021-04-1714

PREAI